Correction to: Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B and glioblastoma (Cell Death & Differentiation, (2014), 21, 5, (720-734), 10.1038/cdd.2013.196);Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma

Cell Death and Differentiation

Volumn 21, Issue 5, 2014, Pages 720-734

  Zhang, Y ^a   Kim, J ^a   Mueller, A C ^a   Dey, B ^a   Yang, Y ^a   Lee, D H ^b   Hachmann, J ^a   Finderle, S ^a   Park, D M ^b   Christensen, J ^c   Schiff, D ^b   Purow, B ^b   Dutta, A ^a   Abounader, R ^a,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

glioblastoma; KLF4; MET; miR 134; receptor tyrosine kinases

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 [[(4 METHYLPHENYL)SULFONYLOXY]ACETAMIDO]SALICYLIC ACID; CRIZOTINIB; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; IMATINIB; K RAS PROTEIN; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; MICRORNA; MICRORNA 134; PLATELET DERIVED GROWTH FACTOR RECEPTOR; S 3I 201; SCATTER FACTOR RECEPTOR; STAT5B PROTEIN; UNCLASSIFIED DRUG; KRAS PROTEIN, HUMAN; MIRN134 MICRORNA, HUMAN; ONCOPROTEIN; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; RAS PROTEIN; STAT5 PROTEIN; STAT5B PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CONTROL; CANCER INHIBITION; CANCER STEM CELL; CANCER SURVIVAL; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE INDUCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; MOUSE; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BRAIN TUMOR; CELL GROWTH; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; GLIOBLASTOMA; HUMANS; MICE; MICRORNAS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS; PYRAZOLES; PYRIDINES; RAS PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; STAT5 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 84898041222     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/s41418-018-0145-0     Document Type: Erratum

References (55)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
2. Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 2003; 9: 1274-1281. (Pubitemid 37151681)
3. Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol 2009; 4: 199-227.
4. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20. (Pubitemid 40094598)
5. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866. (Pubitemid 44629897)
6. Zhang Y, Dutta A, Abounader R. The role of microRNAs in glioma initiation and progression. Front Biosci 2012; 17: 700-712.
7. Cortez MA, Nicoloso MS, Shimizu M, Rossi S, Gopisetty G, Molina JR et al. miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma. Genes Chromosomes Cancer 2010; 49: 981-990.
8. Gabriely G, Yi M, Narayan RS, Niers JM, Wurdinger T, Imitola J et al. Human glioma growth is controlled by microRNA-10b. Cancer Res 2011; 71: 3563-3572.
9. Guessous F, Alvarado-Velez M, Marcinkiewicz L, Zhang Y, Kim J, Heister S et al. Oncogenic effects of miR-10b in glioblastoma stem cells. J Neurooncol 2013; 112: 153-163.
10. Godlewski J, Nowicki MO, Bronisz A, Nuovo G, Palatini J, De Lay M et al. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell 2010; 37: 620-632.
11. Fareh M, Turchi L, Virolle V, Debruyne D, Almairac F, de-la-Forest Divonne S et al. The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell Death Differ 2012; 19: 232-244.
12. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008; 455: 1124-1128.
13. Tay YM, Tam WL, Ang YS, Gaughwin PM, Yang H, Wang W et al. MicroRNA-134 modulates the differentiation of mouse embryonic stem cells, where it causes post-transcriptional attenuation of Nanog and LRH1. Stem Cells 2008; 26: 17-29.
14. Fiore R, Khudayberdiev S, Christensen M, Siegel G, Flavell SW, Kim TK et al. Mef2-mediated transcription of the miR379-410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels. EMBO J 2009; 28: 697-710.
15. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M et al. A brain-specific microRNA regulates dendritic spine development. Nature 2006; 439: 283-289. (Pubitemid 43128846)
16. Christensen M, Larsen LA, Kauppinen S, Schratt G. Recombinant Adeno-Associated Virus-Mediated microRNA Delivery into the Postnatal Mouse Brain Reveals a Role for miR-134 in Dendritogenesis in Vivo. Front Neural Circuits 2010; 3: 16.
17. Gaughwin P, Ciesla M, Yang H, Lim B, Brundin P. Stage-specific modulation of cortical neuronal development by Mmu-miR-134. Cereb Cortex 2011; 21: 1857-1869.
18. Gao J, Wang WY, Mao YW, Graff J, Guan JS, Pan L et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010; 466: 1105-1109.
19. Laddha SV, Nayak S, Paul D, Reddy R, Sharma C, Jha P et al. Genome-wide analysis reveals downregulation of miR-379/miR-656 cluster in human cancers. Biol Direct 2013; 8: 10.
20. CBTRUS. Central Brain Tumor Registry of the United States. CBTRUS: Chicago, IL, 1998.
21. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev 2001; 15: 1311-1333. (Pubitemid 32524640)
22. Network CGAR. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455: 1061-1068.
23. Stommel JM, Kimmelman AC, Ying H, Nabioullin R, Ponugoti AH, Wiedemeyer R et al. Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science 2007; 318: 287-290. (Pubitemid 47574858)
24. Szerlip NJ, Pedraza A, Chakravarty D, Azim M, McGuire J, Fang Y et al. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response. Proc Natl Acad Sci USA 2012; 109: 3041-3046.
25. Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer 2003; 3: 459-465. (Pubitemid 37328850)
26. Normanno N, Tejpar S, Morgillo F, De Luca A, Van Cutsem E, Ciardiello F. Implications for KRAS status and EGFR-targeted therapies in metastatic CRC. Nat Rev Clin Oncol 2009; 6: 519-527.
27. Liang QC, Xiong H, Zhao ZW, Jia D, Li WX, Qin HZ et al. Inhibition of transcription factor STAT5b suppresses proliferation, induces G1 cell cycle arrest and reduces tumor cell invasion in human glioblastoma multiforme cells. Cancer Lett 2009; 273: 164-171.
28. Sherry MM, Reeves A, Wu JK, Cochran BH. STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells 2009; 27: 2383-2392.
29. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64: 7011-7021. (Pubitemid 39331011)
30. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401. (Pubitemid 39551674)
31. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756-760. (Pubitemid 44949604)
32. Kelly JJ, Stechishin O, Chojnacki A, Lun X, Sun B, Senger DL et al. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Stem Cells 2009; 27: 1722-1733.
33. Mazzoleni S, Politi LS, Pala M, Cominelli M, Franzin A, Sergi Sergi L et al. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res 2010; 70: 7500-7513.
34. Li Y, Li A, Glas M, Lal B, Ying M, Sang Y et al. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proc Natl Acad Sci USA 2011; 108: 9951-9956.
35. Joo KM, Jin J, Kim E, Ho Kim K, Kim Y, Gu Kang B et al. MET signaling regulates glioblastoma stem cells. Cancer Res 2012; 72: 3828-3838.
36. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 2006; 444: 761-765. (Pubitemid 44949605)
37. Guessous F, Zhang Y, Kofman A, Catania A, Li Y, Schiff D et al. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle 2010; 9: 1031-1036.
38. Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res 2009; 69: 7569-7576.
39. Ernst A, Campos B, Meier J, Devens F, Liesenberg F, Wolter M et al. De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. Oncogene 2010; 29: 3411-3422.
40. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 2008; 68: 9125-9130.
41. Shinojima N, Tada K, Shiraishi S, Kamiryo T, Kochi M, Nakamura H et al. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res 2003; 63: 6962-6970. (Pubitemid 37322983)
42. Abounader R, Laterra J. Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro Oncol 2005; 7: 436-451. (Pubitemid 41555616)
43. Shih AH, Holland EC. Platelet-derived growth factor (PDGF) and glial tumorigenesis. Cancer Lett 2006; 232: 139-147. (Pubitemid 43170963)
44. Yeh HJ, Silos-Santiago I, Wang YX, George RJ, Snider WD, Deuel TF. Developmental expression of the platelet-derived growth factor alpha-receptor gene in mammalian central nervous system. Proc Natl Acad Sci USA 1993; 90: 1952-1956. (Pubitemid 23069975)
45. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676. (Pubitemid 44233629)
46. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872. (Pubitemid 350138099)
47. Jun HJ, Bronson RT, Charest A. Inhibition of EGFR induces a c-MET driven stem cell population in glioblastoma. Stem Cells 2013; e-pub ahead of print 1 October 2013; doi:10.1002/stem.1554.
48. Holmen SL, Williams BO. Essential role for Ras signaling in glioblastoma maintenance. Cancer Res 2005; 65: 8250-8255. (Pubitemid 41330589)
49. Guha A, Feldkamp MM, Lau N, Boss G, Pawson A. Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 1997; 15: 2755-2765. (Pubitemid 28004565)
50. Heldin CH. Protein tyrosine kinase receptors. Cancer Surv 1996; 27: 7-24.
51. Li H, Ahonen TJ, Alanen K, Xie J, LeBaron MJ, Pretlow TG et al. Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade. Cancer Res 2004; 64: 4774-4782. (Pubitemid 38924520)
52. Latha K, Li M, Chumbalkar V, Gururaj A, Hwang Y, Dakeng S et al. Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter. Int J Cancer 2013; 132: 509-520.
53. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9: 391-403. (Pubitemid 43668737)
54. Tiwari N, Meyer-Schaller N, Arnold P, Antoniadis H, Pachkov M, van Nimwegen E et al. Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8). PLoS One 2013; 8: e57329.
55. Li Y, Guessous F, Kwon S, Kumar M, Ibidapo O, Fuller L et al. PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations. Cancer Res 2008; 68: 1723-1731. (Pubitemid 351416557)